Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Ranbaxy Laboratories Limited New Delhi IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-106 - Rev 00 of Ranbaxy Laboratories Limited New Delhi In

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-106 - Rev 00 of Ranbaxy Laboratories Limited New Delhi In 1

20

Ranbaxy Laboratories Limited New Delhi In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Cefradine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-106 - Rev 00

This Chemical Type CEP, issued on January 06, 2004, remains in force until March 11, 2004, ensuring its reliability within the pharmaceutical industry.

Substance Number 814 associated with this CEP further emphasizes